John Maher

Company: Leucid Bio

Job title: Chief Scientific Officer

Seminars:

CAR-T Cell Immunotherapy of Solid Tumours: Parallel Learning from the Clinic & Lab 12:00 pm

Summary of a dise escalation phase 1 clinical trial of panErbB CAR-T cells patients with head and neck cancer Summary of a novel CAR platform dubbed a parallel (p)CAR, which consists of a CD28-containing second generation CAR and a 4-1BB containing chimeric costimulatory receptor pCAR engineered T-cells demonstrate superior restimulation potential in vitro, and exert…Read more

day: Day 1 - Track A - Morning